Validation of the UPPS-P Impulsive Behavior Scale and Clinical Correlates of its Scores in French-Speaking Patients Starting a Residential Detoxification Program.
Addiction
Comorbidity
Impulsivity
Risk factors
Substance use disorder
UPPS-P
Journal
Indian journal of psychological medicine
ISSN: 0253-7176
Titre abrégé: Indian J Psychol Med
Pays: United States
ID NLM: 7910727
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
medline:
29
9
2023
pubmed:
29
9
2023
entrez:
29
9
2023
Statut:
ppublish
Résumé
Impulsivity is a multifaceted construct that plays a prominent role in substance use disorder (SUD). The UPPS-P model distinguishes five impulsivity components (positive urgency, negative urgency, lack of perseverance, lack of premeditation, and sensation seeking). This study aimed to explore the structure of the UPPS-P in patients hospitalized for SUDs and to investigate the relationship between the dimensions of impulsivity and clinical variables. Inpatients of a residential detoxification service ( The factor analysis supported a model of impulsivity with five interrelated latent variables. Good internal consistency was found. External validity was supported by relationships with psychological difficulties. Multiple correlations (Kendall) suggested that, except for its sensation-seeking component, impulsivity is a significant risk factor for both the severity of addictive problems and their comorbidities. This study provides further evidence in favor of the 5-dimensional model of impulsivity. It highlights impulsivity as a transdiagnostic risk factor that should be considered in the management of SUD.
Sections du résumé
Background
UNASSIGNED
Impulsivity is a multifaceted construct that plays a prominent role in substance use disorder (SUD). The UPPS-P model distinguishes five impulsivity components (positive urgency, negative urgency, lack of perseverance, lack of premeditation, and sensation seeking). This study aimed to explore the structure of the UPPS-P in patients hospitalized for SUDs and to investigate the relationship between the dimensions of impulsivity and clinical variables.
Method
UNASSIGNED
Inpatients of a residential detoxification service (
Results
UNASSIGNED
The factor analysis supported a model of impulsivity with five interrelated latent variables. Good internal consistency was found. External validity was supported by relationships with psychological difficulties. Multiple correlations (Kendall) suggested that, except for its sensation-seeking component, impulsivity is a significant risk factor for both the severity of addictive problems and their comorbidities.
Conclusion
UNASSIGNED
This study provides further evidence in favor of the 5-dimensional model of impulsivity. It highlights impulsivity as a transdiagnostic risk factor that should be considered in the management of SUD.
Identifiants
pubmed: 37772148
doi: 10.1177/02537176231157411
pii: 10.1177_02537176231157411
pmc: PMC10523520
doi:
Types de publication
Journal Article
Langues
eng
Pagination
503-510Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Compr Psychiatry. 2014 Nov;55(8):1960-7
pubmed: 25176623
Psychol Bull. 2008 Nov;134(6):807-28
pubmed: 18954158
Psychol Bull. 1990 Mar;107(2):238-46
pubmed: 2320703
Asia Pac Psychiatry. 2018 Sep;10(3):e12318
pubmed: 29687631
Ann N Y Acad Sci. 2019 Sep;1451(1):71-91
pubmed: 30291624
Addict Behav Rep. 2017 Oct 18;6:118-122
pubmed: 29450246
Addiction. 1997 Mar;92(3):313-24
pubmed: 9219393
Behav Ther. 2008 Jun;39(2):107-16
pubmed: 18502244
Rev Epidemiol Sante Publique. 2011 Oct;59(5):327-40
pubmed: 21925817
Indian J Psychol Med. 2018 Nov-Dec;40(6):517-527
pubmed: 30533947
Psychol Assess. 2015 Dec;27(4):1129-46
pubmed: 25822833
Psychopathology. 1996;29(2):139-44
pubmed: 8861519
J Pers Assess. 2010 Jan;92(1):70-7
pubmed: 20013458
Subst Abuse Treat Prev Policy. 2021 Feb 27;16(1):20
pubmed: 33639969
Addict Behav Rep. 2015 Apr 24;2:19-22
pubmed: 29531990
Int J Occup Med Environ Health. 2012 Jun;25(2):178-84
pubmed: 22528542
Dtsch Arztebl Int. 2014 Apr 18;111(16):280-6
pubmed: 24791755
Psychopharmacology (Berl). 2008 Sep;200(1):1-26
pubmed: 18600315
Eur Addict Res. 2019;25(5):213-223
pubmed: 31112984
Alcohol Res. 2019 Jan 01;40(1):
pubmed: 31649834
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Neuropharmacology. 2021 Feb 1;183:108402
pubmed: 33189766
Compr Psychiatry. 2012 Jul;53(5):609-15
pubmed: 22036009
J Psychosom Res. 1994 Jan;38(1):23-32
pubmed: 8126686
Assessment. 2007 Jun;14(2):155-70
pubmed: 17504888
Addiction. 2000 Aug;95 Suppl 2:S189-210
pubmed: 11002914
Drug Alcohol Rev. 2012 Jan;31(1):81-90
pubmed: 21450046
Drug Alcohol Depend. 2017 Sep 1;178:408-416
pubmed: 28709080
Curr Opin Psychiatry. 2008 Jan;21(1):14-8
pubmed: 18281835
Front Psychol. 2017 Dec 13;8:2159
pubmed: 29326620
Psychopathology. 2010;43(3):180-8
pubmed: 20375540
BMC Psychiatry. 2017 Jul 6;17(1):244
pubmed: 28683772
Pharmacol Biochem Behav. 2018 Jan;164:106-117
pubmed: 28778737
Perspect Psychol Sci. 2011 Nov;6(6):589-609
pubmed: 26168379
Drug Alcohol Rev. 2015 Mar;34(2):119-34
pubmed: 24684591
Drug Alcohol Depend. 2015 Sep 1;154:1-13
pubmed: 26072219
J Behav Ther Exp Psychiatry. 2011 Jun;42(2):225-32
pubmed: 21315886